Related Experiment Video
Updated: Jun 14, 2026
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation
Bin Fang1, Eric B Haura, Keiran S Smalley
1Proteomics, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Abstract:
Phosphorylation acts as a molecular switch for many regulatory events in signaling pathways that drive cell division, proliferation, and apoptosis. Because of the critical nature of these protein post-translational modifications in cancer, drug development programs often focus on inhibitors for kinases and phosphatases, which control protein phosphorylation. Numerous kinase inhibitors have entered clinical use, but prediction of their efficacy and a molecular basis for patient response remain uncertain. Chemical proteomics, the combination of drug affinity chromatography with mass spectrometry, identifies potential target proteins that bind to the drugs. Phosphorylation profiling can complement chemical proteomics by cataloging modifications in the target kinases and their downstream substrates using phosphopeptide enrichment and quantitative mass spectrometry. These experiments shed light on the mechanism of disease development and illuminate candidate biomarkers to guide personalized therapeutic strategies. In this review, commonly applied technologies and workflows are discussed to illustrate the role of proteomics in examining tumor biology and therapeutic intervention using kinase inhibitors.
Insights
Proteomics and phosphorylation profiling help identify kinase inhibitor targets and patient biomarkers. This aids in understanding cancer mechanisms and developing personalized therapies for improved treatment efficacy.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Protein phosphorylation is a critical regulatory mechanism in cell signaling pathways.
- Dysregulated phosphorylation is implicated in cancer development and progression.
- Kinase inhibitors are a key therapeutic strategy, but their efficacy and patient response prediction remain challenging.
Purpose of the Study:
- To review technologies and workflows for applying proteomics in cancer research.
- To illustrate the role of proteomics in examining tumor biology and therapeutic intervention with kinase inhibitors.
- To highlight the potential of phosphorylation profiling in identifying drug targets and biomarkers.
Main Methods:
- Chemical proteomics using drug affinity chromatography and mass spectrometry to identify drug targets.
- Phosphorylation profiling via phosphopeptide enrichment and quantitative mass spectrometry.
- Integration of chemical proteomics and phosphorylation profiling for comprehensive analysis.
Main Results:
- Identification of potential target proteins interacting with kinase inhibitors.
- Cataloging of phosphorylation modifications in target kinases and downstream substrates.
- Illumination of molecular mechanisms underlying cancer development and drug response.
Conclusions:
- Proteomics approaches, including chemical proteomics and phosphorylation profiling, are essential for understanding kinase inhibitor mechanisms.
- These methods can identify candidate biomarkers for personalized therapeutic strategies in cancer.
- Integrating proteomics data aids in deciphering tumor biology and optimizing kinase inhibitor-based treatments.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:02Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...